CLINICAL TRIALS PROFILE FOR FORTAZ IN PLASTIC CONTAINER

All Clinical Trials for FORTAZ IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01784445 ↗	Post ERCP Pancreatitis Prevention in Average Risk Patients	Completed	University Hospital Rijeka	Phase 4	2013-06-01	Diclophenac potassium and ceftazidime are commercially available drugs that are used in various clinical situations. They are safe and known for years. Diclophenac potassium and Ceftazidime have been used in some studies for the prophylaxis and treatment of pancreatitis and Post-ERCP Pancreatitis (PEP). Diclophenac potassium, together with indometacin is currently standard treatment for prevention of (PEP) while ceftazidime is possible alternative treatment for patients with contraindications for nonsteroidal medicines. The aim of the study is to evaluate the efficacy of Ceftazidime for the prophylaxis of PEP.

Clinical Trial Conditions for FORTAZ IN PLASTIC CONTAINER

Condition Name

Condition Name for FORTAZ IN PLASTIC CONTAINER
Intervention	Trials
Pancreatitis	1

Condition MeSH

Condition MeSH for FORTAZ IN PLASTIC CONTAINER
Intervention	Trials
Pancreatitis	1

Clinical Trial Locations for FORTAZ IN PLASTIC CONTAINER

Trials by Country

Trials by Country for FORTAZ IN PLASTIC CONTAINER
Location	Trials
Croatia	1

Clinical Trial Progress for FORTAZ IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for FORTAZ IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	1

Clinical Trial Status

Clinical Trial Status for FORTAZ IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for FORTAZ IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for FORTAZ IN PLASTIC CONTAINER
Sponsor	Trials
University Hospital Rijeka	1

Sponsor Type

Sponsor Type for FORTAZ IN PLASTIC CONTAINER
Sponsor	Trials
Other	1